On June 9, 2008, the Supreme Court rendered its verdict, reversing the Fed. Cir., in Quanta Computer Inc., et al. v. LG Electronics, Inc. The following summarizes the Court's findings:
Legal principle: “The longstanding doctrine of patent exhaustion provides that the initial authorized sale of a patented item terminates all patent rights to that item.”
LG Electronics, Inc. (LGE) licensed a number of patents covering microprocessor and chipset technology to Intel Corporation (Intel), who manufactured microprocessors and chipsets and sold them to Defendants. In accordance with the agreement between LGE and Intel, Intel notified defendants that, although it was licensed to sell the products to them, they were not authorized under the agreement to combine the products with non-Intel products. LGE sued Defendants asserting that the combination of microprocessors or chipsets with other computer components infringed LGE's patents covering those combinations. LGE did not assert patent rights in the microprocessors or chipsets themselves.
The district court granted summary judgment of noninfringement on the grounds that, with the exception of the '509 patent (see above), LGE's rights in any system claims were exhausted and further, that LGE was contractually barred from asserting infringement of the '509 patent against the Defendants. The trial court further determined that there was no implied license to any of the Defendants.
The Fed. Cir. noted that the patents asserted by LGE did not cover the products licensed or sold by Intel, but only products when combined with additional components. The Fed. Cir. further noted that Intel's sale of the components to defendants were conditional in that Intel's customers were expressly prohibited from infringing LGE's combination patents. Citing Mitchell v. Hawley 4), the Fed. Cir. found that the patent exhaustion doctrine does not apply to an expressly conditional sale or license. With regard to method claims, the Fed. Cir. approved the trial court's refusal to apply the exhaustion doctrine to the method claims because “the sale of a device does not exhaust a patentee's rights in its method claims” (citing Glass Equip. Dev., Inc. v. Besten, Inc. 5).
Amici
Amici